FDA recall announcement
0.9% recall 2026
Otsuka ICU Medical LLC announced a recall of 0.9% Sodium Chloride Injection, USP, 100 mL. FDA lists the reason as: Product mix-up where 0.9% Sodium Chloride Injection, USP overwrap may contain 10 mEq Potassium Chloride Injection
Product mix-up where 0.9% Sodium Chloride Injection, USP overwrap may contain 10 mEq Potassium Chloride Injection
- FDA publish date
- September 21, 2026
- Company
- Otsuka ICU Medical LLC
- Product
- 0.9% Sodium Chloride Injection, USP, 100 mL
- Last checked
- September 23, 2026
- NDC / identifier
- No specific identifier listed in this announcement
- Affected lot(s)
- No specific lot listed for this clarification
What the FDA announcement says
Product mix-up where 0.9% Sodium Chloride Injection, USP overwrap may contain 10 mEq Potassium Chloride Injection
Read the original FDA recall announcement →
What to check on the package
- Confirm the exact product and brand name.
- Compare the manufacturer or distributor.
- Match the NDC or product identifier.
- Match the lot or code exactly; a drug name alone is not enough.
What to do
Do not stop or change a prescribed medication based only on this page. Contact a pharmacist, prescriber, or the recalling company for instructions specific to your product.
Related FDA enforcement records
59 matching records appear in the current 24-month openFDA snapshot. Use the search tool to compare the exact manufacturer, NDC, and lot.
Source and limitations
This server-rendered page summarizes an FDA source and the openFDA enforcement snapshot last checked on September 23, 2026. It is not an FDA service and does not provide individual medical advice.